Enhanced indoleamine 2,3-dioxygenase activity in patients with severe sepsis and septic shock

Journal of Infectious Diseases

Volumn 201, Issue 6, 2010, Pages 956-966

  Tattevin, Pierre ^a,d   Monnier, Delphine ^b,e   Tribut, Olivier ^c,d   Dulong, Joelle ^e,f   Bescher, Nadège ^c   Mourcin, Frederic ^e,f   Uhel, Fabrice ^a   Le Tulzo, Yves ^a,d   Tarte, Karin ^b,e  

^a Service de Reanimation   (France)

^b Ecology and Ecosystem Health   (France)

^c RENNES UNIVERSITY HOSPITAL   (France)

^d INSERM   (France)

^e INSERM U917   (France)

^f ETABLISSEMENT FRANÇAIS DU SANG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; GAMMA INTERFERON; HLA DR ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDOLEAMINE 2,3 DIOXYGENASE; TOLL LIKE RECEPTOR;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME ACTIVITY; ENZYME DEGRADATION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; IN VITRO STUDY; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; SEPSIS; SEPTIC SHOCK;

ADULT; AGED; CASE-CONTROL STUDIES; CD4 LYMPHOCYTE COUNT; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; FLOW CYTOMETRY; FRANCE; HLA-DR ANTIGENS; HUMANS; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; MALE; MIDDLE AGED; NF-KAPPA B; SEPSIS; SHOCK, SEPTIC; T-LYMPHOCYTES, REGULATORY; YOUNG ADULT;

EID: 77749243148     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/650996     Document Type: Article

References (50)

1. Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med 2003;348:138-150.
2. Annane D, Bellissant E, Cavaillon JM. Septic shock. Lancet 2005; 365: 63-78.
3. Monneret G, Venet F, Pachot A, Lepape A. Monitoring immune dysfunctions in the septic patient: a new skin for the old ceremony. Mol Med 2008; 14:64-78.
4. Le Tulzo Y, Pangault C, Gacouin A, et al. Early circulating lymphocyte apoptosis in human septic shock is associated with poor outcome. Shock 2002; 18:487-494.
5. Venet F, Pachot A, Debard AL, et al. Increased percentage of CD4+CD25+ regulatory T cells during septic shock is due to the decrease of CD4+CD25- lymphocytes. Crit Care Med 2004;32:2329-2331.
6. -) contribute to lymphocyte anergy in septic shock patients. Intensive Care Med 2009; 35:678-686.
7. Fumeaux T, Pugin J. Is the measurement of monocytes HLA-DR expression useful in patients with sepsis? Intensive Care Med 2006; 32: 1106-1108.
8. Monneret G, Finck ME, Venet F, et al. The anti-inflammatory response dominates after septic shock: association of low monocyte HLA-DR expression and high interleukin-10 concentration. Immunol Lett 2004; 95:193-198.
9. Pangault C, Le Tulzo Y, Tattevin P, Guilloux V, Bescher N, Drenou B. Down-modulation of granulocyte macrophage-colony stimulating factor receptor on monocytes during human septic shock. Crit Care Med 2006;34:1193-1201.
10. von Knethen A, Tautenhahn A, Link H, Lindemann D, Brune B. Activation-induced depletion of protein kinase C alpha provokes desensitization of monocytes/macrophages in sepsis. J Immunol 2005; 174: 4960-4965.
11. Pachot A, Cazalis MA, Venet F, et al. Decreased expression of the fractalkine receptor CX3CR1 on circulating monocytes as new feature of sepsis-induced immunosuppression. J Immunol 2008; 180:6421-6429.
12. Adib-Conquy M, Adrie C, Fitting C, Gattolliat O, Beyaert R, Cavaillon JM. Up-regulation of MyD88s and SIGIRR, molecules inhibiting Tolllike receptor signaling, in monocytes from septic patients. Crit Care Med 2006;34:2377-2385.
13. Williams MA, White SA, Miller JJ, et al. Granulocyte-macrophage colony-stimulating factor induces activation and restores respiratory burst activity in monocytes from septic patients. J Infect Dis 1998; 177:107-115.
14. Williams MA, Withington S, Newland AC, Kelsey SM. Monocyte anergy in septic shock is associated with a predilection to apoptosis and is reversed by granulocyte-macrophage colony-stimulating factor ex vivo. J Infect Dis 1998; 178:1421-1433.
15. Le Tulzo Y, Pangault C, Amiot L, et al. Monocyte human leukocyte antigen-DR transcriptional downregulation by Cortisol during septic shock. Am J Respir Crit Care Med 2004; 169:1144-1151.
16. Docke WD, Randow F, Syrbe U, et al. Monocyte deactivation in septic patients: restoration by IFN-gamma treatment. Nat Med 1997; 3:678-681.
17. + regulatory T lymphocytes inhibit lipopolysaccharide-induced monocyte survival through a Fas/Fas ligand-dependent mechanism. J Immunol 2006; 177: 6540-6547.
18. Monneret G, Lepape A, Voirin N, et al. Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock. Intensive Care Med 2006;32:1175-1183.
19. Docke WD, Hoflich C, Davis KA, et al. Monitoring temporary immunodepression by flow cytometric measurement of monocytic HLADR expression: a multicenter standardized study. Clin Chem 2005; 51: 2341-2347.
20. Mellor AL, Munn DH. IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat Rev Immunol 2004; 4:762-774.
21. Jung ID, Lee MG, Chang JH, et al. Blockade of indoleamine 2,3-dioxygenase protects mice against lipopolysaccharide-induced endotoxin shock. J Immunol 2009; 182:3146-3154.
22. Murray MF. Tryptophan depletion and HIV infection: a metabolic link to pathogenesis. Lancet Infect Dis 2003;3:644-652.
23. Pellegrin K, Neurauter G, Wirleitner B, Fleming AW, Peterson VM, Fuchs D. Enhanced enzymatic degradation of tryptophan by indoleamine 2,3-dioxygenase contributes to the tryptophan-deficient state seen after major trauma. Shock 2005;23:209-215.
24. Tas SW, Vervoordeldonk MJ, Hajji N, et al. Non-canonical NF-κB signaling in dendritic cells is required for indoleamine 2,3-dioxygenase (IDO) induction and immune regulation. Blood 2007; 110(5): 1540-1549.
25. von Bergwelt-Baildon MS, Popov A, Saric T, et al. CD25 and indoleamine 2,3-dioxygenase are up-regulated by prostaglandin E2 and expressed by tumor-associated dendritic cells in vivo: additional mechanisms of T-cell inhibition. Blood 2006; 108:228-237.
26. + T cells triggers indoleamine 2,3-dioxygenase activity in dendritic cells. J Immunol 2004; 172:4100-4110.
27. Krause P, Singer E, Darley PI, Klebensberger J, Groettrup M, Legier DF. Prostaglandin E2 is a key factor for monocyte-derived dendritic cell maturation: enhanced T cell stimulatory capacity despite IDO. J Leukoc Biol 2007;82:1106-1114.
28. Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003;31:1250-1256.
29. Le Gall JR, Klar J, Lemeshow S, et al. The Logistic Organ Dysfunction system: a new way to assess organ dysfunction in the intensive care unit. ICU Scoring Group. JAMA 1996;276:802-810.
30. Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993;270:2957-2963.
31. Ida JA, Shrestha N, Desai S, Pahwa S, Hanekom WA, Haslett PA. A whole blood assay to assess peripheral blood dendritic cell function in response to Toll-like receptor stimulation. J Immunol Methods 2006; 310:86-99.
32. Maby-El Hajjami H, Ame-Thomas P, Pangault C, et al. Functional alteration of the lymphoma stromal cell niche by the cytokine context: role of indoleamine-2,3 dioxygenase. Cancer Res 2009; 69:3228-3237.
33. Adib-Conquy M, Adrie C, Moine P, et al. NF-κB expression in mononuclear cells of patients with sepsis resembles that observed in lipopolysaccharide tolerance. Am J Respir Crit Care Med 2000; 162:1877-1883.
34. Kawai T, Akira S. Signaling to NF-kappaB by Toll-like receptors. Trends Mol Med 2007; 13:460-469.
35. Hainz U, Obexer P, Winkler C, et al. Monocyte-mediated T-cell suppression and augmented monocyte tryptophan catabolism after human hematopoietic stem-cell transplantation. Blood 2005; 105:4127-4134.
36. Logters TT, Laryea MD, Altrichter J, et al. Increased plasma kynurenine values and kynurenine-tryptophan ratios after major trauma are early indicators for the development of sepsis. Shock 2009; 32:29-34.
37. Huttunen R, Syrjanen J, Aittoniemi J, et al. High activity of indoleamine 2,3 dioxygenase enzyme predicts disease severity and case fatality in bacteremic patients. Shock 2010; 33(2):149-154.
38. Payen D, Lukaszewicz AC, Belikova I, et al. Gene profiling in human blood leucocytes during recovery from septic shock. Intensive Care Med 2008;34:1371-1376.
39. Pachot A, Lepape A, Vey S, Bienvenu J, Mougin B, Monneret G. Systemic transcriptional analysis in survivor and non-survivor septic shock patients: a preliminary study. Immunol Lett 2006; 106:63-71.
40. +CD25 high regulatory T cells by promoting maturation of LPS-treated dendritic cells. Eur J Immunol 2007; 37:3054-3062.
41. Martins PS, Brunialti MK, Martos LS, et al. Expression of cell surface receptors and oxidative metabolism modulation in the clinical continuum of sepsis. Crit Care 2008; 12:R25.
42. Thomas SR, Salahifar H, Mashima R, Hunt NH, Richardson DR, Stocker R. Antioxidants inhibit indoleamine 2,3-dioxygenase in IFN-γ-activated human macrophages: posttranslational regulation by pyrrolidine dithiocarbamate. J Immunol 2001; 166:6332-6340.
43. Braun D, Longman RS, Albert ML. A two-step induction of indoleamine 2,3 dioxygenase (IDO) activity during dendritic-cell maturation. Blood 2005; 106:2375-2381.
44. Yanagawa Y, Iwabuchi K, Onoe K. Co-operative action of interleukin10 and interferon-γ to regulate dendritic cell functions. Immunology 2009; 127:345-353.
45. + population induces T cell suppression and Th2 polarization in sepsis. J Exp Med 2007; 204:1463-1474.
46. Serbina NV, Hohl TM, Cherny M, Pamer EG. Selective expansion of the monocytic lineage directed by bacterial infection. J Immunol 2009; 183:1900-1910.
47. Nagai Y, Garrett KP, Ohta S, et al. Toll-like receptors on hematopoietic progenitor cells stimulate innate immune system replenishment. Immunity 2006;24:801-812.
48. Geissmann F, Auffray Q Palframan R, et al. Blood monocytes: distinct subsets, how they relate to dendritic cells, and their possible roles in the regulation of T-cell responses. Immunol Cell Biol 2008; 86:398-408.
49. + T-cell proliferation by inducing indoleamine 2,3-dioxygenase in plasmacytoid dendritic cells. Blood 2007; 109:3351-3359.
50. Robinson CM, Hale PT, Carlin JM. NF-κ B activation contributes to indoleamine dioxygenase transcriptional synergy induced by IFN-gamma and tumor necrosis factor-alpha. Cytokine 2006;35:53-61.